Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thymoma × Etoposide × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 124 Lymphoma, Large B-Cell, Diffuse 77 Lymphoma, Non-Hodgkin 75 Small Cell Lung Carcinoma 70 Hodgkin Disease 57 Precursor Cell Lymphoblastic Leukemia-Lymphoma 54 Leukemia 53 Burkitt Lymphoma 52 Lung Neoplasms 46 Lymphoma, Follicular 43 Lymphoma, Mantle-Cell 39 Lymphoma, Large-Cell, Immunoblastic 38 Leukemia, Myeloid, Acute 37 Leukemia, Lymphocytic, Chronic, B-Cell 33 Multiple Myeloma 29 Carcinoma, Non-Small-Cell Lung 26 Recurrence 24 Lymphoma, B-Cell, Marginal Zone 24 Neuroblastoma 21 Central Nervous System Neoplasms 20 Ovarian Neoplasms 17 Sarcoma 16 Dendritic Cell Sarcoma, Interdigitating 16 Congenital Abnormalities 15 Breast Neoplasms 15 Brain Neoplasms 15 Neoplasms, Plasma Cell 14 Myelodysplastic Syndromes 13 Lymphoma, Large-Cell, Anaplastic 13 Neoplasms 12

Interventions

Sunitinib 5 Paclitaxel 4 Carboplatin 4 pembrolizumab 3 Cyclophosphamide 3 Cisplatin 3 selinexor 2 Taxes 2 Ramucirumab 2 Radiotherapy 2 Octreotide 2 N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2 Erlotinib Hydrochloride 2 Chemoradiotherapy 2 zimberelimab 1 saracatinib 1 regorafenib 1 lenvatinib 1 epacadostat 1 envafolimab 1 belinostat 1 avelumab 1 atezolizumab 1 amrubicin 1 TP protocol 1 Radiofrequency Ablation 1 Radiation Dose Hypofractionation 1 Prednisone 1 Pemetrexed 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00387868 2014-12-09

Preoperative Treatment of Patients With High Risk Thymoma

Valley Health System

Phase 2 Completed

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡